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ABSTRACT 1 
Background: Sympatho-adrenal responses are activated as an innate defense coping (DefS) 2 
mechanism during emotional stress. Whether these sympatho-adrenal responses drive cardiac 3 
troponin T (cTnT) increases are unknown. Therefore, associations between cTnT and 4 
sympatho-adrenal responses were assessed.  5 
Methods: A prospective bi-ethnic cohort, excluding atrial fibrillation, myocardial infarction 6 
and stroke cases, was followed for 3 years (N=342; 45.6±9.0 years). We obtained serum 7 
high-sensitive cTnT and outcome measures [Coping-Strategy-Indicator, depression/Patient-8 
Health-Questionnarie-9, 24h BP, 24h heart-rate-variability (HRV) and 24h urinary 9 
catecholamines]. 10 
Results: cTnT levels of the cohort remained similar over 3 years but recovery to cTnT-11 
negative levels was higher in Blacks. Blacks showed moderate depression (45% vs. 16%) and 12 
24h hypertension (67% vs. 42%) prevalence compared to Whites. A receiver-operating-13 
characteristics cTnT cut-point 4.2 ng/L predicting hypertension in Blacks was used as binary 14 
exposure measure in relation to outcome measures [AUC 0.68 (95% CI 0.60-0.76); 15 
sensitivity/specificity 63/70%; P≤0.001]. In cross-sectional analyses, elevated cTnT was 16 
related to DefS [OR 1.08 (95% CI 0.99-1.16); P=0.06]; 24h BP [OR 1.03-1.04 (95% CI 1.01-17 
1.08); P≤0.02] and depressed HRV [OR 2.19 (95% CI 1.09-4.41); P=0.03] in Blacks, but not 18 
in Whites. At 3 year follow-up, elevated cTnT was related to attenuated urine 19 
norepinephrine:creatinine ratio in Blacks [OR 1.46 (95% CI 1.01-2.10); P=0.04]. In Whites, a 20 
cut point of 5.6 ng/L cTnT predicting hypertension was not associated with outcome 21 
measures.  22 
Conclusion: Central neural control systems exemplified a brain-heart stress pathway. 23 
Desensitization of sympatho-adrenal responses occurred with initial neural- (HRV) followed 24 
by neuroendocrine dysfunction (norepinephrine:creatinine) in relation to elevated cTnT. 25 
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Chronic defensiveness may thus drive the desensitization or physiological depression, 1 
reflecting ischemic heart disease risk at a 4.2 ng/L cTnT cut-point in Blacks. 2 
Keywords: defense; depression; heart-rate-variability; catecholamine, cardiac-Troponin T  3 
4 
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1. INTRODUCTION 1 
Coping with everyday stressors (Amirkhan, 1990) may disturb sympatho-adrenal activity 2 
and cardiac rhythmicity as indicated by changes in catecholamine turnover (de Kock et al., 3 
2012) as well as heart-rate variability (HRV) (Malan et al., 2013). Particularly, defensive 4 
coping (DefS) or the fight-flight response encompassing perception of control and active 5 
problem solving, has been suggested as a promoter of health (Amirkhan, 1990). In spite of 6 
this view, DefS outcomes have also been linked with pathology and emotional distress 7 
related alterations (de Kock et al., 2012; Malan et al., 2013), in that attenuated sympatho-8 
adrenal responses to acute mental stress in a cross-sectional analysis were associated with 9 
wall remodeling and silent myocardial ischemia in a Black male cohort (Malan & Malan, 10 
2017). Therefore, it seems plausible that chronic defensiveness, reflecting emotional 11 
distress, may drive direct relationships between sympatho-adrenal activation and markers 12 
of cardiac injury (Lazzarino et al., 2013) such as elevated cardiac troponin (cTnT) levels.  13 
A subunit of the troponin complex, namely cTnT is released in response to sympathetic 14 
activation or catecholamine overload and myocyte necrosis (Muthu et al., 2014). A 15 
decrease in the metabolic supply to the myocardial tissue results in ischemia and resultant 16 
cardiomyocyte necrosis of the myocardium (Muthu et al., 2014). If reduced metabolic 17 
supply is accompanied by catecholamine vascular responsiveness, myocardial ischemia 18 
and cTnT-related damage may further increase (Mazzeo et al., 2014; Muthu et al., 2014). 19 
Resultant changes in cardiac autonomic modulation and blood pressure may therefore 20 
occur to counteract myocardial ischemia, in order to improve perfusion. Accumulative 21 
effects of higher chronic metabolic demands may also be taxing if emotional distress is 22 
present (Malan et al., 2016) To maintain metabolic homeostasis, central neural control and 23 
downstream adrenergic-related signaling will be apparent with either 24 
sensitization/upregulation in acute or desensitization/downregulation in chronic situations 25 
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(Guilliams & Edwards, 2010). Therefore, we aimed to assess sympatho-adrenal outcome 1 
measures, including 24h urinary catecholamines, 24h heart-rate-variability (HRV), blood 2 
pressure and levels of coping and depression in a bi-ethnic cohort from South Africa. 3 
Sympatho-adrenal responses resembling emotional distress might translate to cTnT 4 
activity at a certain cut point indicative of future ischemic heart disease risk. Thus, the 5 
main aim was to examine prospective associations between binary exposure cTnT and 6 
sympatho-adrenal outcome measures. 7 
8 
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2. METHODS 1 
2.1 Study design 2 
The Sympathetic activity and Ambulatory Blood Pressure in Africans (SABPA) prospective 3 
study (Figure 1) was conducted in 2008/9 and 2011/12 and included 409 Black and White 4 
teachers (Malan et al., 2015). For the current sub-study, we only included teachers 5 
participating in both phases and additionally excluded individuals with atrial fibrillation 6 
(N=10), a history of myocardial infarction or stroke (N=3) and missing cTnT data at baseline 7 
(N=4). The final study sample comprised of 342 participants who were fully informed about 8 
the objectives and procedures prior to recruitment. All participants provided written, 9 
informed consent. The study conformed to the Helsinki Declaration (revised 2004) and was 10 
approved by the Ethics Review Board of the North-West University, Potchefstroom Campus, 11 
South Africa: Approval number 0003607S6.  12 
The three-year follow up investigation was performed using a similar methodology to the 13 
baseline evaluation with clinical assessments done over a 36h period. During the working 14 
week, 24h ambulatory blood pressure, -ECG and 24h physical activity devices were fitted to 15 
the participants at their working place after which they resumed normal daily activities. After 16 
15:00, participants were transported to the North-West University overnight facilities, where 17 
they were introduced to the experimental set-up. Afterwards they enjoyed a standardized 18 
dinner, and completed a battery of psychosocial questionnaires under supervision of 19 
registered clinical psychologists. The next morning, anthropometric (Supplementary 20 
Methods) and sphygmomanometer blood pressure measurements were obtained and 21 
registered nursing staff collected overnight fasting blood samples after 07:00.  22 
23 
L Malan et al., 7 
 
2.2 Cardiovascular risk measures 1 
2.2.1 Ambulatory BP and ECG monitoring (ABPM) 2 
ABPM devices were attached to participants' non-dominant arm (Meditech CE120 3 
CardioTens®; Meditech, Budapest, Hungary) by trained cardiovascular research personnel. 4 
The Cardiotens® was programmed to measure BP at 30-min intervals during the day (07:00–5 
22:00) and every hour during night time (22:00–06:00). The successful 24h inflation rate was 6 
79% (±12) at baseline and 88% (±9) at follow-up. The data were analyzed with the 7 
CardioVisions 1.19 Personal Edition software (Meditech, Budapest, Hungary). Any incidents 8 
including visual disturbances, headaches, nausea, fainting, palpitations, physical activity and 9 
stress were to be recorded on a 24-hour diary card. Hypertensive status was classified as 24h 10 
SBP ≥ 130 mm Hg and/or DBP ≥ 80 mm Hg (Piepoli et al., 2016). 11 
2.2.2 Frequency and Time-domain heart-rate-variability (HRV) analyses 12 
Ambulatory HRV analyses assessed spontaneous oscillations resulting from sinus node 13 
depolarization (Thayer et al., 2012) obtained from analyzable 24h ambulatory 2-lead ECG 14 
data. The software program automatically filtered out ventricular and supraventricular ectopic 15 
beats as well as artefacts in RR intervals, while HRV outliers were manually removed. HRV 16 
measures included the standard deviation of the normal-to-normal (NN) intervals between 17 
adjacent QRS complexes (SDNN) which reflected vagus nerve-mediated autonomic control 18 
of the heart. SDNN is the best overall prognostic tool to detect depressed HRV (<100ms) 19 
(Pizzi et al., 2008). HRV triangular index (HRVti) is an index of the pulse variability based 20 
on a triangular interpolation method in the given time interval. In-depth explanations on 21 
frequency and time-domain analyses are well-described on-line (Supplementary Methods). 22 
Additionally, non-linear analyses plotted each RR interval of a sinus beat as a function of the 23 
previous one for a predetermined segment length (Poincaré or Lorenz return maps/plots). 24 
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Quantitative analyses of these plots have been associated with long-term 24h RR-interval 1 
variability (SD2) (Pizzi et al., 2008).  2 
2.2.3 Clinic blood pressure 3 
Participants were in a semi-recumbent position for 20-30 minutes prior to blood pressure 4 
measurements using the Riva-Rocci Korotkoff method by applying a suitable cuff on the 5 
non-dominant arm (Riester CE 0124® and 1.3M TM Littman® II S.E. Stethoscope 2205). 6 
Two duplicate measurements were taken, with a 3- to 5-minute resting period between each; 7 
the second of which was used for statistical analyses. Hypertensive status was classified as 8 
SBP ≥ 140 mm Hg and/or DBP ≥ 90 mm Hg (Piepoli et al., 2016). 9 
2.3 Coping Strategy Indicator (CSI) 10 
The CSI is a 33-item self-report measure of coping responses with construct, convergent and 11 
discriminant validity (Amirkhan, 1990). Cronbach’s alpha (α) reliability coefficients were 12 
determined for the three subscales of 11 items each in the SABPA cohort and ranged between 13 
0.61-0.87. DefS implies actively solving problems and in-control responses. Seeking social 14 
support supports DefS, with a focus on acquiring advice in stressful times and lastly, 15 
emotional avoidance or loss-of-control implies defeat, with psychophysiological withdrawal. 16 
When responding to the various questions of the three subscales, the participant had to keep a 17 
recent stressful event in mind. The responses were then rated on a three-point Likert scale: a 18 
lot (3), a little (2), or not at all (1). The events fell into four broad categories: achievement 19 
(work/school related problems); social stressors (interpersonal conflict); personal changes in 20 
psychophysiological or spiritual status; and fate events such as accidents and chance 21 
victimization (Amirkhan, 1990). Two research assistants sorted these events with an 88% 22 
agreement. 23 
 24 
 25 
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2.4 Depression  1 
Depression symptoms scores were obtained via the PHQ-9 (Kroenke & Spitzer, 2002) which 2 
has been validated in various ethnic groups for use in primary health care settings (Monohan 3 
et al., 2009). Each item evaluated the presence of one of the nine Diagnostic and Statistical 4 
Manual of Mental Disorders, Fourth Edition (DSM-IV-R) criteria for major depression. The 5 
Cronbach’s alpha-reliability index for the total three-year PHQ-9 score in the current sub-6 
study was 0.80, indicating good reliability. The recommended and established PHQ-9 cut-off 7 
point of ≥ 10 indicates the presence of moderately severe depression symptoms. 8 
2.5 Biochemical measurements 9 
2.5.1 Urinary Catecholamines  10 
Urine collection was performed overnight, 8h sampling at baseline and 24h sampling at 11 
follow-up. The sampling periods of 8h and 24h compares favorably for detection of stress 12 
hormones in urine (Masi et al., 2004). At follow-up, participants began and ended sampling 13 
with an empty bladder on Day 1. Urine was collected for the next 24 hours in a three liter 14 
container, washed with 9 ml of 20% HCl (UriSet24, Sarstedt®, Nümbrecht, Germany). 15 
Samples were stored at -80°C until analysis within one year after collection, using the 3-Cat 16 
Urine ELISA Fast Track kit (LDN, Nordhorn, Germany). Intra- and inter-assay coefficients 17 
for epinephrine were 5.50% and 9.62% respectively and for norepinephrine, 2.70% and 18 
8.59%. Urine creatinine was measured with the calorimetric method. 19 
2.5.2 Blood analyses 20 
A registered nurse obtained fasting blood samples from the ante-brachial vein branches with 21 
a sterile winged infusion set, and handled samples according to standardized procedures. 22 
Serum and whole blood EDTA samples were analyzed for lipids, high sensitivity C-reactive 23 
protein (CRP), cotinine (reflecting smoking status), gamma glutamyl transferase (γ-GT) 24 
(reflecting alcohol consumption) and glycated haemoglobin (HbA1c), using Unicel DXC 800, 25 
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Beckman and Coulter, USA; Modular ROCHE Automized, Switzerland and the KonelabTM 1 
20I Sequential Multiple Analyzer Computer, ThermoScientific, Vantaa, Finland respectively. 2 
Citrate fibrinogen was measured by the Viscosity-based clotting method and the Immuno-3 
turbidimetric method (STA Compact, TAGO Diagnostic, Roche; France). The 4 
CRP:fibrinogen ratio was used as marker of fibrosis (Jansen van Vuren et al., 2016). Thyroid 5 
stimulating hormone (TSH) and high sensitive cTnT were determined with 6 
electrochemiluminescence immunoassay (ECLIA), Elecsys 2010, Roche, Basel, Switzerland. 7 
Eighty cTnT values (23.39%) were below detectable limit (<3 ng/L) and substituted with 8 
lower than detectable values using log-methods. The cTnT inter- and intra-batch variability 9 
was 15% and 5.6%.  10 
2.6 Statistical analyses 11 
Statistica version 13 and IBM SPSS version 23 statistical software packages were used. 12 
Power analyses were performed to obtain relevant effect sizes based on differences in 13 
ambulatory autonomic dysfunction and biological profiles. Results showed that a sample size 14 
of 50 will demonstrate biological differences with a statistical power of 0.8, and significance 15 
level of 0.05. Variables with skewed distributions were log-transformed. Covariates were 16 
chosen a priori (Piepoli et al., 2016) including: age, waist circumference, physical activity, γ-17 
GT, cotinine, hypertension medication as well as TSH for HRV analyses. Considering retinal 18 
perfusion deficits and the high hypertension prevalence in Blacks (Malan et al., 2016b) 19 
optimal cTnT cut points associated with clinic and ambulatory 24h hypertension were 20 
computed from the maximum of the Youden index (J) (sensitivity + specificity − 1) using 21 
non-parametric receiver operating characteristic (ROC) curves. General linear modelling was 22 
used to test a priori hypotheses (Ethnicity x Gender x cTnT) using the derived cTnT cut point 23 
as binary exposure measure for outcome risk markers, independent of a priori covariates and 24 
baseline values of the respective risk factors. Sympatho-adrenal outcome measures included 25 
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24h urinary catecholamines, 24h heart-rate-variability (HRV), blood pressure and levels of 1 
coping and depression. Independent t-tests and Chi-square (χ²) tests compared sympatho-2 
adrenal differences and proportions at baseline respectively. ANCOVA analyses compared 3 
sympatho-adrenal values at baseline and follow-up; as well as at follow-up in relation to 4 
elevated ROC cTnT cut point, controlling for a priori covariates and baseline value of the 5 
respective risk factors. Positive cTnT cases were determined at cut points 3ng/L and 4.2ng/L 6 
levels; Chi-square (χ²) tests were used to examine changes in cTnT caseness between baseline 7 
and follow up (i.e., negative results at baseline becoming cTnT-positive at follow-up; and 8 
cTnT-positive people at baseline recovering to cTnT-negative at follow-up). McNemar’s 9 
case-control tests were used to demonstrate changes in high DefS and stressful coping events 10 
over 3 years. Non-linear HRV analyses, using Poincaré and Lorenz plots, were recorded in a 11 
Black male having chronic depressed SDNN (<100ms), DefS (≥31), 24h hypertension and 12 
raised cTnT.  13 
Logistic regression analyses calculated odds ratios (OR) and 95% confidence intervals (CI) to 14 
determine if sympathy-adrenal outcome measures will increase the risk of raised cTnT. These 15 
analyses were performed to examine cross-sectional and longitudinal associations. For the 16 
latter we used the formula: ∆ %: (follow-up – baseline)/baseline*100. Sympatho-adrenal 17 
outcome measures were added independently and in combination to multivariate models, 18 
considering baseline a priori covariates and TSH in HRV models. Sensitivity analyses were 19 
additionally computed to adjust for gender in HRV analyses and excluding HIV cases. The 20 
statistical significance level was set at p ≤ 0.05 (two-tailed).  21 
22 
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3. RESULTS 1 
3.1 Clinical characteristics 2 
In Table 1, Blacks at baseline were younger, physically less active, consumed more alcohol 3 
(γ-GT), and had lower TSH and time-domain HRV values compared to Whites. More Blacks 4 
showed moderate depression (45.0% vs. 16.2%) and 24h hypertension (67% vs. 42%) 5 
prevalence compared to Whites. Blacks further used more ACE inhibitors, diuretics and 6 
calcium channel blockers (P≤0.05).  7 
In Figure 2, a receiver-operating-characteristics (ROC) cTnT cut-point of 4.2 ng/L predicted 8 
both clinic [AUC 0.64 (95% CI 0.55-0.72); sensitivity/specificity 63/64%; P≤0.002] and 9 
ambulatory 24h hypertension [AUC 0.68 (95% CI 0.60-0.76); sensitivity/specificity 63/70%; 10 
P≤0.001] in Blacks. In Whites, the cTnT cut-point of 5.6 ng/L [AUC 0.67 (95% CI 0.58-11 
0.75); sensitivity/specificity 53/78%; P≤0.001] predicted ambulatory 24h hypertension only. 12 
An interaction term (ethnicity x cTnT) was fitted for DefS [F (1,324), 6.40; P = 0.01] but not 13 
for the other coping strategies or depression. Ethnic differences were evident for cTnT, BP, 14 
time-domain HRV and the catecholamines (P≤0.001).  15 
Unadjusted (Table A.1) comparisons showed that Blacks consistently sought more social 16 
support compared to Whites. Blacks further had depressed HRV (lower time-domain SDNN, 17 
increased SDNN risk (≤100ms), lower geometric (HRVti) HRV patterns), higher fibrosis, 18 
blood pressure and lower catecholamine levels compared to Whites. In adjusted comparisons, 19 
a similar trend was observed in Blacks in relation to elevated cTnT (Table 2, 20 
Whites=reference group). Except for SDNN and HRVti, none of the other frequency or time-21 
domain HRV measures showed significant cross-sectional and longitudinal differences or 22 
associations with elevated cTnT considering confounders and will not be discussed further.  23 
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cTnT levels remained similar in the bi-ethnic cohort over 3 years. In Table A.2, the recovery 1 
of cTnT-positive people at baseline to cTnT-negative at follow-up was more apparent at 2 
cTnT cut point < 3 ng/L in Blacks (49.7% in Blacks vs. 32.4% in Whites; p≤ 0.001).  3 
Coping with social stress or interpersonal conflict (Table A.3) showed increased changes 4 
(3.46%) over time in relation to elevated cTnT in Blacks [OR 0.52 (95% CI: 0.26-1.05), 5 
P=0.06].  6 
A composite profile demonstrated a dispersed complex-like pattern with non-linear analysis, 7 
i.e. 2-dimensional Poincaré plotting (Figure A.1) and 3-dimensional Lorenz mapping (Figure 8 
A.2) in a Black male with high defensive coping (DefS score = 31); hypertension (24h BP = 9 
143/91 mmHg); moderately depressed HRV (SDNN = 73ms); medium cardiovascular risk 10 
(HRV triangular index = 9) and raised cTnT (mean 5.1ng/L).  11 
3.2 Cross-sectional associations between sympatho-adrenal responses and elevated 12 
cTnT 13 
In Table 3, an increased risk for cardiac injury at baseline was evident in Blacks when 14 
habitually using DefS (P=0.06), accompanied by moderately depressed time-domain HRV 15 
responses (P=0.03) and increased 24h BP (SBP, DBP) (P≤ 0.02). Apart from fibrosis [OR 16 
0.63 (95% CI: 0.41-0.97); P=0.04], elevated cTnT cut-point (5.6 ng/L) was not associated 17 
with any sympatho-adrenal responses in Whites (Table A.4).  18 
3.3 Follow-up associations between sympatho-adrenal responses and elevated cTnT 19 
At follow-up (Table 3), cardiac injury risk was related to desensitized 20 
norepinephrine:creatinine ratio [OR 1.46 (1.01-2.10); P=0.04] in Blacks.  21 
Sensitivity analyses adjusting for gender in HRV analyses and excluding HIV cases did not 22 
change the outcomes. 23 
24 
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4. DISCUSSION 1 
We assessed cross-sectional and longitudinal associations between cardiac injury (cTnT) and 2 
sympatho-adrenal responses in a bi-ethnic cohort of South African teachers. Major central 3 
neural control systems exemplified a brain-heart-axis stress pathway. The pathway 4 
demonstrated desensitized sympatho-adrenal responses in relation to elevated cTnT levels 5 
with initial neural- (HRV) followed by neuroendocrine dysfunction 6 
(norepinephrine:creatinine). Chronic defensiveness may drive this desensitization; reflecting 7 
a physiological depression and ischemic heart disease risk at a novel 4.2 ng/L cTnT cut-point 8 
in a Black South African cohort.  9 
4.1 Chronic defensiveness reflecting cardiac injury 10 
Healthy coping strategies integrate central neural responses in order to cope with stress 11 
(Vaillant, 2011). Survival circuits and defense responses are activated when threatening 12 
conditions are detected in the amygdala and a general arousal state is generated in the 13 
paraventricular nuclei of the hypothalamus (Moscarello & LeDoux, 2013). This state is due 14 
to widespread fast acting neural-induced involuntary heart rate variations and the release of 15 
slower neuroendocrine aminergic neuromodulators (Moscarello & LeDoux, 2013; Thayer et 16 
al., 2012). Individual resiliency will thus depend on the capacity of the individual to recover 17 
from the stressor by means of healthy in-control coping strategies with a voluntary 18 
mobilizing of social support from friends or family (Amirkhan, 1990; Malan et al., 2017). 19 
Currently, the Black cohort sought more social support, which supports an in-control DefS 20 
response albeit increasing interpersonal conflict and social stress. Indeed, coping defensively 21 
with a social stressor showed a trend for elevated cTnT risk in the current Black cohort. 22 
Chronic DefS with social stress further showed susceptibility for physiological loss-of-23 
control sympatho-adrenal responses. Previous findings support this notion as an urban-24 
dwelling environment and accompanying acculturation was deemed a psychosocial stressor 25 
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(Malan et al., 1996). In 1018 Blacks from the North-West Province of South Africa, DefS 1 
and seeking social support were associated with loss-of-control cardiometabolic responses 2 
(Hamer & Malan, 2010). Our data additionally showed that chronic DefS further may 3 
increase susceptibility for cardiac injury at a cTnT 4.2 ng/L cut-point for Blacks opposed to a 4 
suggested cut point of 6ng/L, or lower, for stress-induced cardiomyopathy (Ramaraj et al., 5 
2009). Interestingly, in Whites, the higher 5.6 ng/L cTnT cut-point predicting ambulatory 6 
hypertension was not related to disturbed sympatho-adrenal responses, and rather exemplified 7 
behavioral in-control DefS responses. Recently F-flurodexoyglucose PET/CTs showed 8 
increased amygdalar activity, which was associated with perceived stress and cardiovascular 9 
disease risk in 293 patients followed for 3.7 years (Tawakol et al., 2017). These findings are 10 
in line with our results in Blacks reflecting chronic defensiveness and cardiac injury over 3 11 
years. Cardiac injury recovery was more apparent at cTnT levels below 3ng/L and support 12 
our findings that cTnT at ≥ 4.2ng/L impeded recovery as concomitant neuroendocrine 13 
dysregulation occurred at these levels. The protective role of estradiol against silent 14 
myocardial events (Malan NT et al., 2017) might explain underlying mechanisms to cardiac 15 
injury recovery.  16 
4.2 Heart rate variation reflecting cardiac injury 17 
Chronic defensiveness or more emotional distress further increases higher metabolic demand 18 
and may disrupt homeostasis with activation of central neural control systems (Patil et al., 19 
2015). In the current study, we demonstrated initial neural control where depressed HRV 20 
responses in relation to elevated cTnT were accompanied by BP increases as homeostatic 21 
reflexes. Indeed, estimators of sympathetic hyperactivity (SDNN <100ms and HRVti) levels 22 
were increased in the Black cohort compared to Whites, further underscoring depressed HRV 23 
and risk for cardiac injury in Blacks.  24 
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The limbic system modulates cardiac activity in response to stressful events and during 1 
homeostatic reflexes (Manea et al., 2015). Sympathetic nervous system (SNS) hyperactivity 2 
may thus serve as a pathophysiological event affecting the reciprocal relationships between 3 
limbic responses, sympathovagal disturbances and raised cTnT. The possibility of 4 
neurocardiogenic injury emerges as a consequence of uncontrolled stress and subsequent 5 
catecholamine overload. Indeed, DefS induces SNS hyperactivity and supports the initial 6 
neural control (depressed HRV, BP increases or hypertensive status) profile at baseline, 7 
reflecting a hypervigilant system. The occurrence of myocardial ischemia and/or myocardial 8 
necrosis during chronic defensiveness may further facilitate a mechanical distortion of the 9 
afferent and efferent fibers of the autonomic nervous system. This may be due to changes in 10 
the geometry related to necrotic and non-contracting segments of the heart (Mazzeo et al., 11 
2014). Changes will also affect local neural regulation and contribute to the resulting 12 
diminished HRV. However, contradictory findings were recently reported (Jandackova et al., 13 
2016). In the UK Whitehall II population-based cohort study, cardiac autonomic modulations 14 
in 3414 men and women obtained over 10 years and at 3 different time points, were not 15 
associated with a higher prevalence of cardiometabolic symptoms but rather with normal 16 
ageing (Jandackova et al., 2016).  17 
4.3 Neuroendocrine dysfunction reflecting cardiac injury 18 
Pertaining to neuroendocrine risk, we could not find any bi-ethnic study reporting a 19 
longitudinal relationship between the catecholamines and cardiac injury. Our findings support 20 
the presence of a novel brain-heart stress pathway. Chronic sympatho-adrenal activation 21 
facilitated a later onset of neuroendocrine control with desensitization of 22 
norepinephrine:creatinine in relation to elevated cTnT in a Black cohort. Previously we have 23 
established that the trigger enzyme for synthesis of the catecholamines, tyrosine hydroxylase 24 
C-824T single nucleotide polymorphism, was not related to hypertension in this Black cohort 25 
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(van Deventer et al., 2013). Therefore, our findings rather support the role of environmental 1 
or social stress demands, which elicited sympatho-adrenal responses in relation to elevated 2 
cTnT in Blacks. The risk of an attenuated norepinephrine:creatinine ratio and elevated cTnT 3 
levels suggests that overwhelming sustained stress may interfere with behavioral in-control 4 
DefS. It may cause distress and hyperactivity of the sympatho-adrenal system, as the body 5 
attempts to cope with increasing demands. Two mechanisms may apply: norepinephrine 6 
levels may a) decrease due to exhaustion of the autonomic system (Guilliams & Edwards, 7 
2010) where adrenal exhaustion or fatigue will set in, and b) the neuroendocrine system will 8 
become non-responsive with desensitization and/or down-regulation of adrenergic receptors, 9 
which has been associated with depression and neural fatigue (Tsigos & Croussos, 2002). 10 
The lack of association between chronic depressive symptoms and cardiac injury was 11 
therefore surprising. Our findings rather support dissociation of DefS responses where 12 
behavioral in-control responses masked physiological loss-of-control or desensitized 13 
responses (physiological depression). This may have a detrimental impact on cardiac health 14 
in the long-term and may increase susceptibility for ischemic heart disease.  15 
4.4 Blood pressure as compensatory mechanism to counteract perfusion deficits and 16 
cardiac injury 17 
Coping defensively with overwhelming social stress (Rosengren et al., 2004) may have 18 
induced BP increases in relation to elevated cTnT at baseline. Concurrently, the hypertension 19 
prevalence rate in the Whites was lower (42%) compared to the Blacks (67%) with no change 20 
in hypertension prevalence in the Black Africans at follow-up. Findings from the 21 
INTERHEART (Rosengren et al., 2004) and Jackson studies (Abdalla et al., 2016) in 22 
African-Americans demonstrated similar findings as social stress was related to myocardial 23 
ischemia and elevations in cTnT respectively. Interestingly, the ambulatory hypertension 24 
status of 59% African-Americans from the Jackson study (Abdalla et al., 2016) compares 25 
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reasonably well with the 67% of our cohort. We, therefore, argue that evidence of vascular 1 
resistance in Blacks (Malan et al., 2012) and African-Americans (Adefurin et al., 2013) might 2 
be driven by chronic defensiveness or a disturbed brain-heart stress response pathway. 3 
Indeed, vascular resistance increases cardiac preload in essential hypertensives (Adefurin et 4 
al., 2013) and impeded coronary perfusion in a Black cohort (Griffiths et al., 2017). 5 
Inevitable this may increase myocardial oxygen demand, which may result in proteolysis and 6 
release of cTnT and increases in blood pressure. Ultimately, loss-of-control DefS in the 7 
Blacks facilitated cardiac injury. Previously, the SABPA Whites showed acute emotional 8 
stress at follow-up (Malan et al., 2016), which aligns well with the current effective in-9 
control DefS where elevated cTnT was not related to sympatho-adrenal responses. Our 10 
findings further suggest that targeting novel markers to explain hypertension prevalence in 11 
the African ethnicity should rather consider central neural control or brain-heart stress 12 
responses. When chronic conditions such as cardiac injury prevail, dynamic compensatory 13 
BP increases may trigger central control mechanisms to maintain homeostatic reflexes in 14 
organ systems.  15 
The small sample size prohibited stratification into both ethnic and gender groups thereby 16 
limiting an improved understanding of cardiac injury pathology. Therefore expanding data to 17 
other cohorts may confirm findings of a 4.2 ng/l cTnT cut-point when chronic defensiveness 18 
is suspected. Early screening for raised cTnT has clinical practice implications as raised cTnT 19 
is shown to be related to neural distress, which may precede ischemic heart disease and future 20 
heart failure risk.  21 
In conclusion, a novel brain-heart stress pathway exemplified desensitized sympatho-adrenal 22 
responses in relation to cardiac injury. Initial desensitized neural- followed by 23 
neuroendocrine dysfunction reflected a chronic physiological depression. Dissociation of 24 
behavioral control (DefS) albeit physiological loss-of-control responses were demonstrated in 25 
the Blacks. Chronic defensiveness may have contributed to loss-of-control neuroendocrine 26 
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responses, facilitating cardiac injury at a 4.2 ng/l cTnT cut-point. Screening for stress-related 1 
cardiac injury at cTnT levels of ≥ 4.2 and ECG ST-segment depression may allow detection 2 
of the early dynamics in ischemic heart disease development. 3 
4 
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Figure 1: Design of the bi-ethnic gender cohort of the Sympathetic Activity and Ambulatory 4 
Blood Pressure in Africans prospective study. Where: cTnT=cardiac troponin T at baseline. 5 
6 
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1-Specificity
Se
ns
itiv
ity
-0.2 0.0 0.2 0.4 0.6 0.8 1.0 1.2
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
cTnT 4.2ng/l predicts 24h hypertension  
cTnT 4.2ng/l predicts Clinic Hypertension
 1 
Figure 2a: ROC curves depicting cardiac Troponin T cut points for clinic and 24h 2 
hypertension in Black Teachers. The area under the curve (AUC) (95% CI) for 24h 3 
hypertension was 0.68 (95% CI 0.60-0.76); sensitivity/specificity 63/70%; P≤0.001; 4 
and for clinic hypertension 0.64 (95% CI 0.55-0.72); sensitivity/specificity 63/64%; 5 
P≤0.002.  6 
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Figure 2b: ROC curves depicting cardiac Troponin T cut points for clinic and 24h 1 
hypertension in Whites. The area under the curve (AUC) (95% CI) for 24h 2 
hypertension was 0.67 (0.58-0.75); sensitivity/specificity 53/78% (P≤0.001); with an 3 
AUC for clinic hypertension of 0.65 (95% CI 0.56-0.74); sensitivity/specificity 4 
52/74%; P≤0.01. 5 
6 
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 1 
Table 1: Clinical characteristics of a bi-ethnic South African teacher’s cohort at baseline.  2 
 Blacks 
(N=169) 
Whites 
(N=173) 
P-
values 
Age, yrs 44.5 (39.0-51.0) 47.0 (41.0-54.0) 0.04 
Women, n (%)  88 (52.1) 82 (47.4) 0.39 
Urban living, years 31.8 (19.0-45.0) 20.5 (10.0-30.0) < 0.001 
Cotinine, ng/ml 0.01 (0.01-15.51) 0.01 (0.01-0.01) 0.33 
cGGT, U/l 43.5 (28.4-74.4) 18.0 (12.0-28.0) < 0.001 
Physical activity, kcal/24h 2584.6 (2185.9-3118.1) 2968.0 (2370.0-3540.7) < 0.001 
Waist circumference, cm 94.1 (83.6-103.1) 93.6 (80.8, 103.5) 0.10 
Coping scores    
Defense coping 29 (15.0-31.0) 30 (27-32) 0.06 
Social support coping 26 (23-30) 18 (15-23) < 0.001 
Avoidance coping 21 (18-23) 23 (21-28) < 0.001 
Moderately severe depression, n 
(%) 
61 (36.09)  22 (12.72) < 0.001 
Heart Rate Variability (HRV)    
SDANN, ms 269.0 (234.0-300.5) 263.1 (219.0-295.5) <0.001 
SDNN, ms 112 (85-136) 124 (102-156) <0.001 
rMSSD, ms 29 (21-38) 31 (22-41) 0.26 
HRV:Triangular index  29 (22-36) 36 (29-43) <0.001 
Thyroid stimulating hormone, 
µlU/ml 
1.8 (1.3-2.5) 2.1 (1.4-2.9)  0.01 
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Potential cardiac and neuroendocrine risk markers 
 
Cardiac Troponin T, ng/L 4.2 (3.1-5.5) 4.9 (3.2-6.9) 0.05 
Cholesterol, mmol/l 4.5 (3.8-5.5) 5.5 (4.7-6.4) < 0.001 
CRP:Fibrinogen, g/L:mg/L 1.4 (0.7-2.6) 0.5 (0.4-1.2) <0.001 
24h SBP, mm Hg 131 (122-143) 124 (116-130) <0.001 
24h DBP, mm Hg 82 (77-90) 77 (71-82) <0.001 
24h Heart rate, bpm  79 (73-86) 74 (68-81) <0.001 
24h Hypertension, n (%)a 113 (67) 73 (42) <0.001 
24h urinary NE:Cr 18.8 (11.6-29.8) 24.8 (13.2-38.9) 0.07 
24h urinary E:Cr 2.9 (1.6-2.9) 2.9 (1.6-4.7) 0.36 
HIV, n (%) 15 (8.9) 0 (0) <0.001 
Medications, n (%)  
Statins 2 (1.2) 6 (3.5) 0.16 
Aspirin 4 (2.4) 9 (5.2) 0.17 
ACE inhibitors 19 (11.2) 3 (1.7) <0.001 
Angiotensin II blockers 1 (0.6) 1 (0.6) 0.99 
Diuretics 23 (13.6) 8 (4.6) <0.001 
Calcium channel blockers 13 (7.7) 1 (0.6) 0.001 
Beta blockers 5 (3.0) 1 (0.6) 0.09 
Alpha blockers 0.0 0.0 - 
Values are median (± interquartile range/IQR) or frequencies (%). Where: cGGT=gamma glutamyl 1 
transferase; moderately depressed=PHQ-9=≥10; CRP=C-reactive protein; HdL=high density 2 
lipoproteins; HIV=Human Immune-deficiency virus infected; SDANN=standard deviation of all the 3 
5 minutes normal RR intervals (NN); SDNN=Standard deviation of RR interval; rMSSD=the square 4 
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root of the mean squared difference of successive NNs; NE:Cr=norepinephrine creatinine ratio; 1 
E:Cr=epinephrine creatinine ratio.  2 
aHypertensive status classified as 24h SBP ≥ 130 mm Hg and/or DBP ≥ 80 mm Hg.10 3 
4 
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Table 2: Comparing sympatho-adrenal response mean changes in Blacks vs. Whites 1 
(reference group) in relation to cardiac troponin T (cTnT) cut points at 3 year follow-up. 2 
 Blacks vs. Whites (reference group) 
 cTnT cut point: 4.2 ng/L cTnT cut point: 5.6 ng/L 
Depression  
Depressive symptoms -0.11 (0.10) -1.62 (0.09) 
Coping scores  
Defense coping 0.27 (0.06) 1.54 (0.17) 
Heart rate variability (HRV)a 
HRV:SDNN, ms -23.58 (0.71)** -22.58 (1.73)* 
HRV:Triangular index -4.35 (0.17)* -4.97 (0.47) 
Potential cardiac and neuroendocrine risk markers 
cTnT, ng/L 1.76 (0.09) 1.15 (0.20) 
Fibrosis -0.15 (0.04) -0.87 (0.12) 
24h SBP, mmHg 6 (0.19)** 7 (0.59)* 
24h DBP, mmHg 3 (0.11)** 3 (0.33) 
24h NE:Cr, nmol/l -18.25 (0.56)** -18.18 (0.99)** 
24h E:Cr, nmol/l -3.20 (0.09)** -3.13 (0.14)** 
Data presented as means ± SEM (standard error of means). Adjustments were made for a 3 
priori covariates (age, log waist circumference, log physical activity, log cotinine, log GGT 4 
and hypertension medication use) and baseline value of the respective risk marker. 5 
SDNN=Standard deviation of RR interval; NE:Cr=urinary norepinephrine creatinine ratio; 6 
E:Cr=urinary epinephrine creatinine ratio.  7 
aAdditional adjustment for thyroid stimulating hormone. *P ≤ 0.05; **P ≤ 0.01. 8 
9 
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Table 3: Sympatho-adrenal responses in relation to cardiac Troponin T (cTnT) cut-point (≥ 1 
4.2 ng/L) in a Black cohort.  2 
 Odds ratio 95% CI P Value 
Cross-sectional   
Coping scores 
Defense coping 1.08 0.99-1.16 0.06 
24h Time-domain heart rate variability (HRV)  
SDNN risk cut point (≤ 100ms) 2.19 1.09-4.41 0.03 
Potential cardiac risk 
24h SBP, mmHg 1.03 1.01-1.06 0.01 
24h DBP, mmHg 1.04 1.01-1.08 0.02 
Follow-up (∆ %) 
Potential neuroendocrine risk 
24h urinary norepinephrine:creatinine ratio. 1.46 1.01-2.10 0.04 
Adjustments were made for baseline a priori covariates (age, log waist circumference, log physical 3 
activity, log cotinine, log GGT and hypertension medication use) and thyroid stimulating hormone 4 
in HRV analyses. Where: SDNN=Standard deviation of RR interval; ∆ = change; NE:Cr=urinary 5 
norepinephrine:creatinine ratio.  6 
 7 
